VICTORVILLE, Calif.--(BUSINESS WIRE)--As part of their mission to expand world-class cancer care into local communities, The Oncology Institute of Hope and Innovation (TOI) opened its first location in the High Desert this week in Victorville, CA.
TOI is a multi-state cancer care practice dedicated to healing and empowering patients through compassion, innovation, and state-of-the-art medical care. TOI is the largest value-based oncology practice in the U.S., taking accountability for both the quality outcomes as well as the medical costs associated with a population of more than 1 million patients. They offer a diverse set of cutting-edge resources including:
- A leading clinical research program offering patients access to more than 130 clinical trials.
- Comprehensive dispensary services to offer convenience and savings to patients receiving oral chemotherapeutics.
- A care management program which helps patients navigate a complex healthcare system.
- A state-of-the-art website with educational resources, scheduling capabilities, and a convenient patient portal.
“At TOI, we believe every patient deserved access to the best possible care in their own community.” says TOI COO, Dr. Daniel Virnich. “We are thrilled to bring our cutting-edge cancer care to the high desert.”
With an ongoing focus on quality patient care, the new location will feature state-of-the-art services in addition to top notch care that is already offered at their existing locations throughout Southern California and across the country. The Victorville clinic is located at:
12408 Hesperia Rd. Suite 1
Victorville, CA 92395
Call (760) 388-0071 for appointments.
About The Oncology Institute of Hope and Innovation
Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is one of the largest community oncology practices in the US as well as our nation’s leading value-based oncology services platform. TOI employs 80+ physicians and advanced practice providers in nearly 50 clinic locations, TOI employs more than 500 total teammates that are dedicated to offering leading-edge, evidence-based cancer care to a population of more than 1 million patients. TOI brings comprehensive, integrated cancer care into community settings, including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care settings. For more information visit www.theoncologyinstitute.com.
